[Retracted] Antileukemic Effects of Anti-miR-146a, Anti-miR-155, Anti-miR-181a, and Prednisolone on Childhood Acute Lymphoblastic Leukemia

Table 5

Annexin V results of SUP-B15 and NCI-BL 2171 cells.

Treatment group	Live cell (%)		Necrotic cell (%)		Apoptotic cell (%)		Apoptotic fold change (to control)
	SUP-B15	NCI-BL 2171	SUP-B15	NCI-BL 2171	SUP-B15	NCI-BL 2171	SUP-B15	NCI-BL 2171
Control	83.30	98.70	16.40	0.90	0.30	0.40	1.00	1.00
IC50 dose of prednisolone	5.70	97.30	84.60	2.20	9.70	0.60	32.30	1.50
Anti-miR-146a	76.20	96.80	23.40	2.80	0.30	0.40	1.00	1.00
Anti-miR-146a & IC50 dose of prednisolone	9.00	98.40	86.00	1.40	4.90	0.20	16.30	0.50
Anti-miR-155	80.70	94.00	15.80	5.40	3.60	0.60	12.00	1.50
Anti-miR-155 & IC50 dose of prednisolone	5.00	98.40	84.00	1.50	11.00	0.10	36.70	0.30
Anti-miR-181a	65.30	98.80	33.40	1.00	1.20	0.20	4.00	0.50
Anti-miR-181a & IC50 dose of prednisolone	4.10	98.70	81.20	1.20	14.70	0.00	49.00	0.00
Anti-let-7e	81.40	98.20	18.50	1.60	0.10	0.30	0.30	0.80
Anti-let-7e & IC50 dose of prednisolone	6.30	98.60	80.10	1.30	13.60	0.00	45.30	0.00
Anti-miR-146a + anti-miR-155 + anti-miR-181a + anti-let-7e combination	74.20	98.40	25.50	1.40	0.30	0.10	1.00	0.30
Anti-miR-146a + anti-miR-155 + anti-miR-181a + anti-let-7e combination & IC50 dose of prednisolone	5.60	98.50	68.10	1.40	26.20	0.10	87.30	0.30

Fisher’s exact test, <0.01, <0.001, and <0.0001.